PMID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40662108,Corrigendum: Community-engaged curriculum development using racial justice and biomedical lenses to address COVID-19 vaccine hesitancy in black individuals with rheumatologic conditions.,2025,"['Denice Garrett', 'Gail Granville', 'Mary Ann Nelson']","['Action for Boston Community Development, Inc., Boston, MA, United States.', 'Mattapan Community Development Corp, Women of Courage, Boston, MA, United States.', 'Mission Hill Health Movement Inc., Roxbury, MA, United States.']",
40660347,ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumors.,2025-Jul-15,"['Daniela Stanga', 'Marina P Gonçalves']","['Research and Development Branch, Defence Therapeutics Inc., Montréal, QC, Canada.', 'Research and Development Branch, Defence Therapeutics Inc., Montréal, QC, Canada.']",
40658038,Assessing the influence of male vaccination on cervical cancer elimination in China under different vaccination coverage scenarios: A modeling study.,2025-Dec,"['Ibrahim Diakite', 'Jeffrey Kyle', 'Sujian Situ', 'Wei Vivian Wang', 'Xingxing Zhang', 'Yin Wang', 'Rui Bian', 'Hai Bin Wu', 'Xu Sheng Wang', 'Ya-Ting Chen', 'Vincent Daniels']","['Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA.', 'Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA.', 'Health Economics and Outcomes Research, MSD China Holding Co., Ltd., Shanghai, China.', 'Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA.', 'MRL Global Medical Affairs, MSD China Holding Co., Ltd., Shanghai, China.', 'MRL Global Medical Affairs, MSD China Holding Co., Ltd., Shanghai, China.', 'MRL Global Medical Affairs, MSD China Holding Co., Ltd., Shanghai, China.', 'MRL Global Medical Affairs, MSD China Holding Co., Ltd., Shanghai, China.', 'Health Economics and Outcomes Research, MSD China Holding Co., Ltd., Shanghai, China.', 'Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA.', 'Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA.']",
40652684,SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population.,2025-Jul-12,"['Kaniel Cassady', 'Erica Chio', 'Andrea T Hooper', 'Matthew F Wipperman']","['Global Development Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.', 'Global Development Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.', 'Global Development Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.', 'Global Development Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.']",
40639020,Approaches to overcome the current treatment plateau in immunotherapy.,2025-Jul-06,"['Wei Zheng', 'Ramy Ibrahim']","['Moderna Inc., 325 Binney St., Cambridge, MA 02139, USA.', 'Georgiamune Inc., 942 Clopper Rd., Gaithersburg, MD 20878, USA.']",
40632771,"Membrane Expression Enhances Folding, Multimeric Structure Formation, and Immunogenicity of Viral Capsid Proteins.",2025-Jul-09,"['Jane Qin', 'Ju Hyeong Jeon', 'Renhuan Xu', 'Hong Cao']","['Advanced RNA Vaccine Technologies, Inc., North Bethesda, Rockville, Maryland 20852, United States.', 'Advanced RNA Vaccine Technologies, Inc., North Bethesda, Rockville, Maryland 20852, United States.', 'Advanced RNA Vaccine Technologies, Inc., North Bethesda, Rockville, Maryland 20852, United States.', 'InnovHope, Inc., Framingham, Massachusetts 01701, United States.']",
